Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Open access
Vermij, Lisa, Jobsen, Jan J., León-Castillo, Alicia, Brinkhuis, Mariel, Roothaan, Suzan, Powell, Melanie E., de Boer, Stephanie M., Khaw, Pearly, Mileshkin, Linda R., Fyles, Anthony, Leary, Alexandra, Genestie, Catherine, Jürgenliemk-Schulz, Ina M., Crosbie, Emma J., Mackay, Helen J., Nijman, Hans. W., Nout, Remi A., Smit, Vincent T. H. B. M., Creutzberg, Carien L., Horeweg, Nanda, Bosse, Tjalling, TransPORTEC Consortium, de Boer, Stephanie M. · 2023 · British Journal of Cancer

Abstract

Background: Risk-assessment of endometrial cancer (EC) is based on clinicopathological factors and molecular subgroup. It is unclear whether adding hormone receptor expression, L1CAM expression or CTNNB1 status yields prognostic refinement. Methods: Paraffin-embedded tumour samples of women with high-risk EC (HR-EC) from the PORTEC-3 trial ( n = 424), and a Dutch prospective clinical cohort called MST ( n = 256), were used. All cases were molecularly classified. Expression of L1CAM, ER and PR were analysed by whole-slide immunohistochemistry and CTNNB1 mutations were assessed with a next-generation sequencing. Kaplan–Meier method, log-rank tests and Cox’s proportional hazard models were used for survival analysis. Results: In total, 648 HR-EC were included. No independent prognostic value of ER, PR, L1CAM, and CTNNB1 was found, while age, stage, and adjuvant chemotherapy had an independent impact on risk of recurrence. Subgroup-analysis showed that only in NSMP HR-EC, ER-positivity was independently associated with a reduced risk of recurrence (HR 0.33, 95%CI 0.15–0.75). Conclusions: We confirmed the prognostic impact of the molecular classification, age, stage, and adjuvant CTRT in a large cohort of high-risk EC. ER-positivity is a strong favourable prognostic factor in NSMP HR-EC and identifies a homogeneous subgroup of NSMP tumours. Assessment of ER status in high-risk NSMP EC is feasible in clinical practice and could improve risk stratification and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-023-02141-0

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

  • FIGO staging of endometrial cancer: 2023

    Berek, J. S., Matias‐Guiu, X., Creutzberg, C., Fotopoulou, C., Gaffney, D., Kehoe, S., Lindemann, K., Mutch, D., Concin, N., & Endometrial Cancer Staging Subcommittee, F. W. C. C. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14923 · Cited by 1,000

    Self-citation
  • FIGO staging of endometrial cancer: 2023

    Berek, J. S., Matias-Guiu, X., Creutzberg, C., Fotopoulou, C., Gaffney, D., Kehoe, S., Lindemann, K., Mutch, D., Concin, N., & Endometrial Cancer Staging Subcommittee, F. W. C. C. (2023) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2023.34.e85 · Cited by 262

    Self-citation

See all 188

Metadata

Authors
Vermij, L., Jobsen, J. J., León-Castillo, A., Brinkhuis, M., Roothaan, S., Powell, M. E., de Boer, S. M., Khaw, P., Mileshkin, L. R., Fyles, A., Leary, A., Genestie, C., Jürgenliemk-Schulz, I. M., Crosbie, E. J., Mackay, H. J., Nijman, H. W., Nout, R. A., Smit, V. T. H. B. M., Creutzberg, C. L., Horeweg, N., Bosse, T., TransPORTEC Consortium, & de Boer, S. M.
Venue
British Journal of Cancer
Published
2023-01-23
Volume
128
Issue
7
Pages
1360-1368
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W4317718278
Cited by
188
References
2
FWCI
51.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. https://app.cochat.ai/papers/10.1038/s41416-023-02141-0
The paper
Vermij, L., Jobsen, J. J., León-Castillo, A., Brinkhuis, M., Roothaan, S., Powell, M. E., de Boer, S. M., Khaw, P., Mileshkin, L. R., Fyles, A., Leary, A., Genestie, C., Jürgenliemk-Schulz, I. M., Crosbie, E. J., Mackay, H. J., Nijman, H. W., Nout, R. A., Smit, V. T. H. B. M., Creutzberg, C. L., . . . de Boer, S. M. (2023). Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. British Journal of Cancer. https://doi.org/10.1038/s41416-023-02141-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.